Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus living in hot climates

AIMS: Patients with type 2 diabetes mellitus (T2DM) have increased risk of adverse events (AEs; e.g. dehydration, hypoglycaemia) in hot weather. This analysis assessed the efficacy and safety of canagliflozin, a sodium glucose co‐transporter 2 (SGLT2) inhibitor, in patients with T2DM who live in hot...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Int J Clin Pract
Главные авторы: John, Mathew, Cerdas, Sonia, Violante, Rafael, Deerochanawong, Chaicharn, Hassanein, Mohamed, Slee, April, Canovatchel, William, Hamilton, Gill
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2016
Предметы:
Endocrinology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5129493/
https://ncbi.nlm.nih.gov/pubmed/27600862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.12868
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы